Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Prostate Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02237612
What this trial is testing

Diffusion-Weighted MRI in Staging Patients With Localized Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateStage IIA Prostate CancerStage IIB Prostate Cancer
University of Southern California 9
Testing effectiveness (Phase 2)Ended earlyNCT00879619
What this trial is testing

Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients

Who this might be right for
Prostate CancerAdenocarcinoma of the ProstateRecurrent Prostate Cancer+3 more
John P. Fruehauf 4
Testing effectiveness (Phase 2)Ended earlyNCT00527124
What this trial is testing

Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Adenocarcinoma of the ProstateStage IV Prostate Cancer
National Cancer Institute (NCI) 57
Not applicableStudy completedNCT00052481
What this trial is testing

Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 500
Early research (Phase 1)Study completedNCT00054106
What this trial is testing

Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
NCIC Clinical Trials Group 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07574541
What this trial is testing

Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance

Who this might be right for
AdenocarcinomaProstate CancerNeoplasms+3 more
National Cancer Institute (NCI) 52
Testing effectiveness (Phase 2)Study completedNCT00151060
What this trial is testing

Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate

Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 28
Testing effectiveness (Phase 2)Ended earlyNCT00003533
What this trial is testing

Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Burzynski Research Institute 12
Testing effectiveness (Phase 2)Study completedNCT01325311
What this trial is testing

Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate CancerStage IIA Prostate Cancer+1 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00096499
What this trial is testing

SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or Paclitaxel

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 40
Not applicableStudy completedNCT02346253
What this trial is testing

High-Dose Brachytherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more
Stanford University 146
Testing effectiveness (Phase 2)Looking for participantsNCT06582628
What this trial is testing

Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)

Who this might be right for
Metastatic Prostate Cancer
Fundacion Oncosur 78
Testing effectiveness (Phase 2)Study completedNCT00085228
What this trial is testing

Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 116
Testing effectiveness (Phase 2)Study completedNCT00570700
What this trial is testing

Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer

Who this might be right for
Hormone-refractory Prostate CancerAdenocarcinoma of the ProstateHormone-resistant Prostate Cancer+2 more
University of California, Irvine 38
Large-scale testing (Phase 3)Active Not RecruitingNCT06205316
What this trial is testing

SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma

Who this might be right for
Biochemically Recurrent Prostate CarcinomaOligometastatic Prostate CarcinomaRecurrent Prostate Adenocarcinoma+4 more
Mayo Clinic 118
Testing effectiveness (Phase 2)Study completedNCT00032006
What this trial is testing

Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 48
Testing effectiveness (Phase 2)Study completedNCT00246753
What this trial is testing

Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT01228084
What this trial is testing

Sulforaphane in Treating Patients With Recurrent Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate Cancer
OHSU Knight Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT00049257
What this trial is testing

Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT01026623
What this trial is testing

Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerProstate AdenocarcinomaRecurrent Prostate Carcinoma+1 more
National Cancer Institute (NCI) 16
Next Page